GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (NAS:HBIO) » Definitions » Cyclically Adjusted PB Ratio

Harvard Bioscience (Harvard Bioscience) Cyclically Adjusted PB Ratio : 1.33 (As of May. 15, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Harvard Bioscience Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Harvard Bioscience's current share price is $3.41. Harvard Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.56. Harvard Bioscience's Cyclically Adjusted PB Ratio for today is 1.33.

The historical rank and industry rank for Harvard Bioscience's Cyclically Adjusted PB Ratio or its related term are showing as below:

HBIO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.5   Med: 1.32   Max: 2.92
Current: 1.34

During the past years, Harvard Bioscience's highest Cyclically Adjusted PB Ratio was 2.92. The lowest was 0.50. And the median was 1.32.

HBIO's Cyclically Adjusted PB Ratio is ranked better than
67.24% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs HBIO: 1.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Harvard Bioscience's adjusted book value per share data for the three months ended in Mar. 2024 was $1.585. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.56 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Harvard Bioscience Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Harvard Bioscience's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Cyclically Adjusted PB Ratio Chart

Harvard Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.49 2.45 0.99 2.04

Harvard Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 2.01 1.60 2.04 1.66

Competitive Comparison of Harvard Bioscience's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Bioscience's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Harvard Bioscience's Cyclically Adjusted PB Ratio falls into.



Harvard Bioscience Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Harvard Bioscience's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.41/2.56
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Harvard Bioscience's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.585/129.4194*129.4194
=1.585

Current CPI (Mar. 2024) = 129.4194.

Harvard Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.047 100.560 3.921
201409 2.989 100.428 3.852
201412 2.932 99.070 3.830
201503 2.715 99.621 3.527
201506 2.796 100.684 3.594
201509 2.778 100.392 3.581
201512 2.284 99.792 2.962
201603 2.295 100.470 2.956
201606 2.234 101.688 2.843
201609 2.208 101.861 2.805
201612 2.096 101.863 2.663
201703 2.100 102.862 2.642
201706 2.159 103.349 2.704
201709 2.205 104.136 2.740
201712 2.310 104.011 2.874
201803 2.223 105.290 2.732
201806 2.118 106.317 2.578
201809 2.171 106.507 2.638
201812 2.213 105.998 2.702
201903 2.132 107.251 2.573
201906 2.120 108.070 2.539
201909 2.026 108.329 2.420
201912 2.139 108.420 2.553
202003 1.981 108.902 2.354
202006 1.967 108.767 2.340
202009 1.980 109.815 2.333
202012 1.946 109.897 2.292
202103 1.930 111.754 2.235
202106 1.944 114.631 2.195
202109 1.884 115.734 2.107
202112 2.027 117.630 2.230
202203 1.852 121.301 1.976
202206 1.868 125.017 1.934
202209 1.728 125.227 1.786
202212 1.716 125.222 1.774
202303 1.762 127.348 1.791
202306 1.766 128.729 1.775
202309 1.740 129.860 1.734
202312 1.684 129.419 1.684
202403 1.585 129.419 1.585

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Harvard Bioscience  (NAS:HBIO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Harvard Bioscience Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Harvard Bioscience (Harvard Bioscience) Business Description

Traded in Other Exchanges
Address
84 October Hill Road, Holliston, MA, USA, 01746
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Executives
James W Green director, officer: Chief Executive Officer 12525 CHADRON AVENUE, HAWTHORNE CA 90250
Alan I Edrick director 20200 SUNBURST STREET, CHATSWORTH CA 91311
Jennifer Cote officer: Interim CFO C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Bertrand Loy director C/O ENTEGRIS, INC., 129 CONCORD RD, BILLERICA MA 01821
Thomas W Loewald director 81 WYMAN STREET, WALTHAM MA 02451
John F Kennedy director C/O NET PERCEPTIONS INC, 7700 FRANCE AVE. SOUTH, EDINA MN 55435
Katherine A. Eade director C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Susan M. Steele director C/O HILL INTERNATIONAL, INC., 2005 MARKET ST., 17TH FLOOR, PHILADELPHIA PA 19103
Kenneth Fletcher Olson officer: Chief Operating Officer C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Michael A. Rossi officer: Chief Financial Officer C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Yash Singh officer: Executive Vice President C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Jeffrey Duchemin officer: Chief Executive Officer 14 EASTLAND TERRACE, HAVERHILL MA 01830
Kamalam Unninayar officer: Chief Financial Officer C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
Robert E. Gagnon officer: Chief Financial Officer C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
George Uveges director C/O MFIC CORPORATION, 30 OSSIPEE ROAD, NEWTON MA 02464